Benedict Cross

Benedict Cross

Company: PhoreMost

Job title: CTO


Discovery of a Novel Functional E3 Binder Through PROTEINi-Enabled Screening 12:00 pm

The development of novel degraders with appropriate drug development properties requires a systematic functional deconvolution of the E3 ligase space The PROTEINi screening developed by PhoreMost has been used to uncover novel phenotypically active peptide ligands from which to build drug discovery pipelines In this seminar, we will show how we have used to thisto…Read more

day: Day 1 AM - Stream A

Chair’s Closing Remarks & End of Pre-Conference Focus Day 3:30 pm

Read more

day: Pre-Conference Focus Day

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.